PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 143 filers reported holding PLIANT THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.42 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,010,376 | -4.3% | 288,949 | 0.0% | 0.53% | -37.0% |
| Q2 2023 | $5,235,756 | -86.2% | 288,949 | -79.8% | 0.84% | -88.7% |
| Q1 2023 | $38,038,000 | +82.2% | 1,430,000 | +32.4% | 7.43% | +111.2% |
| Q4 2022 | $20,876,400 | -7.5% | 1,080,000 | 0.0% | 3.52% | +1.0% |
| Q3 2022 | $22,561,000 | – | 1,080,000 | – | 3.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 339,160 | $5,881,034 | 100.00% |
| CHI Advisors LLC | 3,014,199 | $52,266,211 | 20.72% |
| TRV GP IV, LLC | 2,132,867 | $36,983,914 | 13.93% |
| GREAT POINT PARTNERS LLC | 1,755,184 | $30,434,891 | 5.54% |
| First Light Asset Management, LLC | 2,933,260 | $50,862,728 | 4.83% |
| Deep Track Capital, LP | 5,500,000 | $95,370,000 | 3.68% |
| Casdin Capital, LLC | 1,577,108 | $27,347,053 | 3.03% |
| Fernwood Investment Management, LLC | 379,702 | $6,584,033 | 2.37% |
| Redmile Group, LLC | 2,678,099 | $46,438,237 | 2.21% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 250,409 | $4,342,092 | 1.32% |